Filing
Spy
Filing
Spy
Home
About
HALO
Halozyme Therapeutics Inc
0.25% Convertible Senior Notes due 2027
CUSIP: 40637H109
Healthcare
US
1 holder
Ownership
Activity
2022 Q4
10 of 25 quarters
Total Value
$825.4K
Total Shares
14.5K
Net Share Change
+14.5K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Pzena Investment Management
$825.4K
14.5K
0.0%
NEW
Pzena Investment Management
$825.4K
14.5K shares
NEW
HALO — Halozyme Therapeutics Inc - FilingSpy